La Chemioprofilassi Con Doxorubicina Nei Carcinomi Superficiali Della Vescica

1 Anderstrom C. , Johanson S. , Nilsson S. : The significance of lamina propria invasion on prognosis of patients with bladder tumors. J. Urol., 124; 23 (1980).

2 Banks M. D. , Pontes J. E. , Izbicki R. M. , Pierce J. M. jr. : Topical instillation of doxorubicin hydrocloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. J. Urol., 118; 757 (1977).

3 Barnes R. W. , Dick A. L. , Hadley H. L. , Johnston O. L. : Survival following transurethral resection of bladder carcinoma. Cancer Res., 37; 2895 (1977).

4 Dalesio O. , Schulman C. C. , Syvester R. , De Pawn M. , Robinson M. , Denis L. , Smith P. , Viggiano G. and Members of the European Organization for Research on Treatment of Cancer: Prognostic factors in superficial bladder tumors. J. Urol., 129; 730 (1983).

5 Edsmyr F. , Berlin T. , Bomen J. , Duchek M. , Esposti P. L. , Gustafsson H. , Wijstrom H. , Collste L. C. : Intravesical therapy with Adriamycin in patients with superficial bladder tumors. Eur. Urol., 6; 132 (1980).

6 Ferraris V. , Pavesi M. , Repetto E. , Pisano P. F. , Albano D. : Profilassi farmacologica delle recidive degli uroteliomi superficiali con doxorubicina endovescicale. Minerva urol., 37; 159 (1985).

7 Fitzpatrick J. M. , Khan O. , Oliver R. T. D. , Riddle P. R. : Long term follow up in patients with superficial bladder tumours treated with intravesical epodyl. Brit. J. Urol., 51; 545 (1979).

8 Gilbert H. A. , Logan J. L. , Kagan A. R. , Friedman H. A. , Cove J. K. , Fox M. , Muldoon T. M. , Lonni Y. M. , Rowe J. H. , Cooper J. F. , Nussbaum H. , Chan P. , Rao A. , Starr A. : The natural history of papillary transitional cell carcinoma of the bladder and its treatment in unselected population on the basis of histologic grading. J. Urol., 119; 488 (1978).

9 Grossman H. B. : Current therapy of bladder carcinoma. J. Urol., 121; 1 (1979).

10 Heney N. M. , Nocks B. N. , Daly J. J. , Prout G. R. jr. , Newall J. B. , Griffin P. P. , Perrone T. L. , Szyfelbein W. A. : Ta and T., bladder cancer: location, recurrence and progression. Brit. J. Urol., 54; 152 (1982).

11 Huland H. , Otto U. : Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of controlled, prospective study in 58 patients. Eur. Urol., 9; 84 (1983).

12 Jacobi G. H. , Kurth K. H. : Studies on the intravesical action of topically administered G3-H-Doxorubicin hydrocloride in men: plasma uptake and tumor penetration. J. Urol., 124; 34 (1980).

13 Jakse G. , Hofstadter F. , Marberger H. : Intracavitary doxorubicin hydrocloride therapy for carcinoma in situ of the bladder T. Urol 125; 185 (1981)

14 Kurth K. H. , Schroder F. H. , Tunn U. , Ay R. , Pavone-Macaluso M. et al.: Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research and treatment of cancer randomized trial comparing Doxorubicin hydrocloride, Ethoglucid and transurethral resection alone. J. Urol., 132; 258 (1984).

15 Lutzeyer W. , Rübben H. , Dahnn H. : Prognostic parameters in superficial bladder cancer: an analysis of 315 cases J. Urol 127; 250 (1982).

16 Miller A. , Mitchell J. P. , Brown N. J. : The Bristol bladder tumor registry. Brit. J. Urol., suppl., 1; 64 (1969).

17 Nieh P. T. , Daly J. J. , Heaney J. A. , Heney N. M. , Prout G. R. jr. : The effect of intravesical Thiotepa on normal and tumor urothelium. J. Urol., 119; 59 (1978).

18 O'Flynn J. D. , Smith J. M. , Hauson J. S. : Transurethral resection for assessment and treatment of vesical neoplasms: a review of 840 consecutive cases. Eur. Urol., 1; 138 (1975)

19 Pavone Macaluso M. , Caramia G. : Adriamycin and Daunomycin in the treatment of vesical and prostatic neoplasia. Preliminary results. In: International Symposium on Adriamicin, p. 180. Carter S. K. , Di Marco A. , Ghione M. , Krakoff I. H. , Mathè G. (eds.). Springer Verlag, Berlin, Heidelberg, New York 1972.

20 Poc'ock R. D. , Ponner B. A. J. , O'Sullivan J. P. , Ibrahim S. K. , Easton D. F. , Shearer R. J. : Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report. Brit. J. Urol., 54; 711 (1982).

21 Pryor J. P. : Factor influencing the survival of patients with transitional cell tumours of urinary bladder. Brit. J. Urol., 45; 586 (1973).

22 Schuhman C. C. : Intravesical chemotherapy for superficial bladder tumors. In: Clinical bladder cancer, p. 101. Denis J. L. , Smith P. H. , Pavone Macaluso M. (eds.). Plenum Press, New York, London 1982.

23 Schuhman C. C. , Robinson M. , Denis L. , Smith P. , Viggiano G. , De Pauw M. , Dalesio O. , Sylvester R. : Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, VM-26, and TUR alone. Eur. Urol., 8; 207 (1982).

24 Smith G. , Theodorou C. , Field G. , Hargreave T. B. , Chisholm G. D. : Intravesical methotrexate in the treatment of superficial bladder cancer. Brit. J. Urol., 56; 663 (1984).

25 Soloway M. S. : The management of superficial bladder cancer. Cancer, 45; 1856 (1980).

26 Soloway M. S. , Murphy W. M. , Defuria M. D. , Crooke S. , Finebaum P. : The effect of Mitomicin C on superficial bladder cancer. J. Urol., 125; 646 (1981).

27 Soloway M. S. , Murphy W. , Rao M. K. , Cox C. : Serial multiple-site biopsies in patients with bladder cancer. J. Urol., 120; 57 (1978).

28 Veenema R. J. , Dean A. L. jr. , Uson A. C. , Roberts M. , Lago F. : Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. J. Urol., 101; 711 (1969).

29 Weyrauch H. M. , Crossfield J. G. : Dissemination of bladder neoplasms by endoscopic electroresection. J. Urol., 87; 391 (1962).

30 Williams J. L. , Hammonds J. C. , Saunders N. : T., bladder tumors. Brit. J. Urol., 49; 663 (1977).